335 related articles for article (PubMed ID: 20610858)
1. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.
Yoda Y; Amagase K; Kato S; Tokioka S; Murano M; Kakimoto K; Nishio H; Umegaki E; Takeuchi K; Higuchi K
J Physiol Pharmacol; 2010 Jun; 61(3):287-94. PubMed ID: 20610858
[TBL] [Abstract][Full Text] [Related]
2. Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis.
Kuroda M; Yoshida N; Ichikawa H; Takagi T; Okuda T; Naito Y; Okanoue T; Yoshikawa T
Int J Mol Med; 2006 Jan; 17(1):89-93. PubMed ID: 16328016
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil, an inhibitor of phosphodiesterase subtype 5, prevents indomethacin-induced small-intestinal ulceration in rats via a NO/cGMP-dependent mechanism.
Kato N; Mashita Y; Kato S; Mitsufuji S; Yoshikawa T; Takeuchi K
Dig Dis Sci; 2009 Nov; 54(11):2346-56. PubMed ID: 19101800
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine.
Pozzoli C; Menozzi A; Grandi D; Solenghi E; Ossiprandi MC; Zullian C; Bertini S; Cavestro GM; Coruzzi G
Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):283-91. PubMed ID: 17151854
[TBL] [Abstract][Full Text] [Related]
5. Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats.
Konaka A; Kato S; Tanaka A; Kunikata T; Korolkiewicz R; Takeuchi K
Pharmacol Res; 1999 Dec; 40(6):517-24. PubMed ID: 10660951
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
Amagase K; Ochi A; Sugihara T; Kato S; Takeuchi K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S111-8. PubMed ID: 20586851
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats.
Kamei K; Kubo Y; Kato N; Hatazawa R; Amagase K; Takeuchi K
Dig Dis Sci; 2008 Oct; 53(10):2657-66. PubMed ID: 18306037
[TBL] [Abstract][Full Text] [Related]
8. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats.
Tanaka A; Kunikata T; Mizoguchi H; Kato S; Takeuchi K
J Physiol Pharmacol; 1999 Sep; 50(3):405-17. PubMed ID: 10574470
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus (FK506), an immunosuppressive agent, prevents indomethacin-induced small intestinal ulceration in the rat: inhibition of inducible nitric oxide synthase expression.
Kato S; Nishio H; Ogura M; Takeuchi K
J Pharmacol Sci; 2007 Jan; 103(1):40-7. PubMed ID: 17202747
[TBL] [Abstract][Full Text] [Related]
10. Cinacalcet, a calcimimetic, prevents nonsteroidal antiinflammatory drug-induced small intestinal damage in rats.
Hayashi S; Kurata N; Kitahirachi E; Nishimura Y; Amagase K; Yano T; Takeuchi K
J Physiol Pharmacol; 2013 Aug; 64(4):453-63. PubMed ID: 24101391
[TBL] [Abstract][Full Text] [Related]
11. Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs.
Takeuchi K; Yokota A; Tanaka A; Takahira Y
Dig Dis Sci; 2006 Jul; 51(7):1250-9. PubMed ID: 16944022
[TBL] [Abstract][Full Text] [Related]
12. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.
Satoh H; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats.
Nishio H; Hayashi Y; Terashima S; Takeuchi K
Inflammopharmacology; 2007 Dec; 15(6):266-72. PubMed ID: 18236018
[TBL] [Abstract][Full Text] [Related]
14. Carbon Monoxide (CO) Released from Tricarbonyldichlororuthenium (II) Dimer (CORM-2) in Gastroprotection against Experimental Ethanol-Induced Gastric Damage.
Magierowska K; Magierowski M; Hubalewska-Mazgaj M; Adamski J; Surmiak M; Sliwowski Z; Kwiecien S; Brzozowski T
PLoS One; 2015; 10(10):e0140493. PubMed ID: 26460608
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons.
Kato S; Tanaka A; Kunikata T; Umeda M; Takeuchi K
Digestion; 2000; 61(1):39-46. PubMed ID: 10671773
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine.
Lim YJ; Phan TM; Dial EJ; Graham DY; Lichtenberger LM
Digestion; 2012; 86(2):171-7. PubMed ID: 22907267
[TBL] [Abstract][Full Text] [Related]
17. Lansoprazole, a proton pump inhibitor, mediates anti-inflammatory effect in gastric mucosal cells through the induction of heme oxygenase-1 via activation of NF-E2-related factor 2 and oxidation of kelch-like ECH-associating protein 1.
Takagi T; Naito Y; Okada H; Ishii T; Mizushima K; Akagiri S; Adachi S; Handa O; Kokura S; Ichikawa H; Itoh K; Yamamoto M; Matsui H; Yoshikawa T
J Pharmacol Exp Ther; 2009 Oct; 331(1):255-64. PubMed ID: 19628634
[TBL] [Abstract][Full Text] [Related]
18. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
[TBL] [Abstract][Full Text] [Related]
19. Activation of α7 nicotinic acetylcholine receptors ameliorates indomethacin-induced small intestinal ulceration in mice.
Kawahara R; Yasuda M; Hashimura H; Amagase K; Kato S; Takeuchi K
Eur J Pharmacol; 2011 Jan; 650(1):411-7. PubMed ID: 20969854
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats.
Konaka A; Nishijima M; Tanaka A; Kunikata T; Kato S; Takeuchi K
J Physiol Pharmacol; 1999 Mar; 50(1):25-38. PubMed ID: 10210152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
